tm
Seeing Is Believing
tm
Seeing Is Believing
RVPH is currently covered by 4 analysts with an average price target of $10.15. This is a potential upside of $9.27 (1053.41%) from yesterday's end of day stock price of $0.88.
Reviva Pharmaceuticals Holdings's activity chart (see below) currently has 2 price targets and 20 ratings on display. The stock rating distribution of RVPH is 94.44% BUY and 5.56% HOLD.
Highest price target for RVPH is $7, Lowest price target is $7, average price target is $9.5.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 22-Jan-2025. First documented stock forecast 26-Jul-2021.
Currently out of the existing stock ratings of RVPH, 17 are a BUY (94.44%), 1 are a HOLD (5.56%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
3 months 7 days ago
(22-Jan-2025)
0/7 (0%)
$15.61 (355.58%)
Buy
$7
$5.99 (593.07%)
3 months 19 days ago
(10-Jan-2025)
0/3 (0%)
$5.12 (272.34%)
Buy
8 months 3 days ago
(26-Aug-2024)
0/1 (0%)
$9.85 (137.76%)
Buy
$12
$10.99 (1088.12%)
$12
1 years 5 months 30 days ago
(30-Oct-2023)
0/2 (0%)
$6.51 (118.58%)
What is RVPH (Reviva Pharmaceuticals Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on RVPH (Reviva Pharmaceuticals Holdings) with a proven track record?
Which analyst has the current lower performing score on RVPH (Reviva Pharmaceuticals Holdings) with a proven track record?
Which analyst has the most public recommendations on RVPH (Reviva Pharmaceuticals Holdings)?
Which analyst is the currently most bullish on RVPH (Reviva Pharmaceuticals Holdings)?
Which analyst is the currently most reserved on RVPH (Reviva Pharmaceuticals Holdings)?
